Table 1.
VEGF-A and VEGF-C expression in relation to the clinicopathologic characteristics of 50 patients with pancreatic cancer
| VEGF-A | VEGF-C | |||||
| + | - | P | + | - | P | |
| Age (yr) | 64 ± 10 | 62 ± 9 | 65 ± 10 | 62 ± 8 | ||
| Gender | ||||||
| Male | 18 | 17 | 28 | 7 | ||
| Female | 7 | 8 | 12 | 3 | ||
| TNM | ||||||
| T1 | 1 | 8 | 0.035 | 8 | 1 | 0.701 |
| T2 | 9 | 7 | 13 | 3 | ||
| T3 | 15 | 10 | 19 | 6 | ||
| N0 | 6 | 5 | 0.733 | 6 | 5 | 0.017 |
| N1 | 19 | 20 | 34 | 5 | ||
| M0 | 20 | 23 | 0.221 | 35 | 8 | 0.541 |
| M1 | 5 | 2 | 5 | 2 | ||
| Stage | ||||||
| I | 0 | 0 | 0.801 | 0 | 0 | 0.416 |
| II | 1 | 2 | 2 | 1 | ||
| III | 5 | 4 | 6 | 3 | ||
| IV | 19 | 19 | 32 | 6 | ||
| Differentiated degree | ||||||
| well | 10 | 5 | 0.290 | 14 | 1 | 0.304 |
| moderate | 13 | 18 | 23 | 8 | ||
| poor | 2 | 2 | 3 | 1 | ||
TNM: tumor node metastasis.